Xbrane is pleased to announce its participation in Carnegie Nordic Healthcare Day in New York in collaboration with the Trout Group, 5 December. The event is for institutional investors and is hosted at the offices of Davis Polk & Wardwell.
The Conference is organized by Carnegie Investment Bank, the Nordic market leader, and the Trout Group, the life science industry's leading investor relations and strategic advisory firm. Xbrane is one of more than 20 companies to present and hold 1 x 1 meetings. For institutional participation please contact email@example.com.
Link to event: https://ebrdg.com/investor.php/c/carnegienordichealthcareday
Xbrane is a commercial phase Swedish biopharmaceutical company specialized in biosimilars and long acting injectables. Xbrane has world leading expertise in developing generics for long acting injectable drugs and proprietary high-yield protein expression technology for the development of biosimilars. Xbrane's headquarter is located in Solna outside of Stockholm and the company's in-house research and development facilities are located in Sweden and Italy. Xbrane is listed at Nasdaq First North since February 3rd, 2016 under the name Xbrane and Avanza Bank AB is Xbrane's certified adviser. For more information seewww.xbrane.com.
For further information, please contact:
M: +46 (0) 763-093 777
CFO/IR, Xbrane Biopharma AB
M: +46 (0) 708-278 636
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Xbrane Biopharma AB via Globenewswire